Cargando…

1404. Tuberculosis and HIV Coinfection: A Review of 135 Cases Experience of the Infectious Diseases Department- CHU Mohamed VI- Marrakech

BACKGROUND: Tuberculosis is a health problem in Morocco, which is increasingly indicative of human immunodeficiency virus (HIV) infection. OBJECTIVE: To determine the epidemiological, clinical and paraclinical, therapeutic and evolutionary aspects of tuberculosis and HIV co-infection. METHODS: we re...

Descripción completa

Detalles Bibliográficos
Autores principales: Alaoui, Zahid Talibi, Raiteb, Mohammed, Ihbibane, Fatima, Soraa, Nabila, Tassi, noura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644706/
http://dx.doi.org/10.1093/ofid/ofab466.1596
_version_ 1784610147737272320
author Alaoui, Zahid Talibi
Raiteb, Mohammed
Ihbibane, Fatima
Soraa, Nabila
Tassi, noura
author_facet Alaoui, Zahid Talibi
Raiteb, Mohammed
Ihbibane, Fatima
Soraa, Nabila
Tassi, noura
author_sort Alaoui, Zahid Talibi
collection PubMed
description BACKGROUND: Tuberculosis is a health problem in Morocco, which is increasingly indicative of human immunodeficiency virus (HIV) infection. OBJECTIVE: To determine the epidemiological, clinical and paraclinical, therapeutic and evolutionary aspects of tuberculosis and HIV co-infection. METHODS: we report 135 cases co-infected with HIV and tuberculosis, collected by the infectious diseases department at the Mohammed VI University Hospital in Marrakech. This is a 12-year retrospective study (2007 to 2020) that involved all HIV-infected patients hospitalized for tuberculosis regardless of its location. RESULTS: The mean age of the patients was 40 years (17-73 years). A male predominance was noted in 69% of cases. In 74.6% of cases, tuberculosis was indicative of HIV infection. Nine patients were receiving antiretroviral (ARV) treatment at the time of the discovery of tuberculosis. There were 24% pulmonary tuberculosis, 25.3% extrapulmonary tuberculosis and 49% disseminated tuberculosis. Tuberculosis was confirmed in 31.7% of cases. At the time of tuberculosis diagnosis, the average CD4 count was 86 cells / mm. Quadruple therapy with isoniazid, rifampicin, pyrazinamide and ethambutol was started in 83% of patients. The average time to start ARVs was 7 weeks. All patients who received ARVs received a combination therapy comprising the combination of 2 nucleoside analogs and one non-nucleoside analog. At the end of our work, the evolution was favorable in 53% of cases, death occurred in 25% of cases, 18.6% of patients were lost to follow-up, two cases of failure and another of relapse. Immune restoration syndrome was noted in 8 cases. Drug toxicity was observed in 24.5% of patients, 73% of which was related to hepato-toxicity of antibacillary drugs. CONCLUSION: Tuberculosis is the most common opportunistic infection in people with HIV. Despite the advent of highly active triple therapy, tuberculosis is still a major cause of death in HIV positive people. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-8644706
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86447062021-12-06 1404. Tuberculosis and HIV Coinfection: A Review of 135 Cases Experience of the Infectious Diseases Department- CHU Mohamed VI- Marrakech Alaoui, Zahid Talibi Raiteb, Mohammed Ihbibane, Fatima Soraa, Nabila Tassi, noura Open Forum Infect Dis Poster Abstracts BACKGROUND: Tuberculosis is a health problem in Morocco, which is increasingly indicative of human immunodeficiency virus (HIV) infection. OBJECTIVE: To determine the epidemiological, clinical and paraclinical, therapeutic and evolutionary aspects of tuberculosis and HIV co-infection. METHODS: we report 135 cases co-infected with HIV and tuberculosis, collected by the infectious diseases department at the Mohammed VI University Hospital in Marrakech. This is a 12-year retrospective study (2007 to 2020) that involved all HIV-infected patients hospitalized for tuberculosis regardless of its location. RESULTS: The mean age of the patients was 40 years (17-73 years). A male predominance was noted in 69% of cases. In 74.6% of cases, tuberculosis was indicative of HIV infection. Nine patients were receiving antiretroviral (ARV) treatment at the time of the discovery of tuberculosis. There were 24% pulmonary tuberculosis, 25.3% extrapulmonary tuberculosis and 49% disseminated tuberculosis. Tuberculosis was confirmed in 31.7% of cases. At the time of tuberculosis diagnosis, the average CD4 count was 86 cells / mm. Quadruple therapy with isoniazid, rifampicin, pyrazinamide and ethambutol was started in 83% of patients. The average time to start ARVs was 7 weeks. All patients who received ARVs received a combination therapy comprising the combination of 2 nucleoside analogs and one non-nucleoside analog. At the end of our work, the evolution was favorable in 53% of cases, death occurred in 25% of cases, 18.6% of patients were lost to follow-up, two cases of failure and another of relapse. Immune restoration syndrome was noted in 8 cases. Drug toxicity was observed in 24.5% of patients, 73% of which was related to hepato-toxicity of antibacillary drugs. CONCLUSION: Tuberculosis is the most common opportunistic infection in people with HIV. Despite the advent of highly active triple therapy, tuberculosis is still a major cause of death in HIV positive people. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2021-12-04 /pmc/articles/PMC8644706/ http://dx.doi.org/10.1093/ofid/ofab466.1596 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstracts
Alaoui, Zahid Talibi
Raiteb, Mohammed
Ihbibane, Fatima
Soraa, Nabila
Tassi, noura
1404. Tuberculosis and HIV Coinfection: A Review of 135 Cases Experience of the Infectious Diseases Department- CHU Mohamed VI- Marrakech
title 1404. Tuberculosis and HIV Coinfection: A Review of 135 Cases Experience of the Infectious Diseases Department- CHU Mohamed VI- Marrakech
title_full 1404. Tuberculosis and HIV Coinfection: A Review of 135 Cases Experience of the Infectious Diseases Department- CHU Mohamed VI- Marrakech
title_fullStr 1404. Tuberculosis and HIV Coinfection: A Review of 135 Cases Experience of the Infectious Diseases Department- CHU Mohamed VI- Marrakech
title_full_unstemmed 1404. Tuberculosis and HIV Coinfection: A Review of 135 Cases Experience of the Infectious Diseases Department- CHU Mohamed VI- Marrakech
title_short 1404. Tuberculosis and HIV Coinfection: A Review of 135 Cases Experience of the Infectious Diseases Department- CHU Mohamed VI- Marrakech
title_sort 1404. tuberculosis and hiv coinfection: a review of 135 cases experience of the infectious diseases department- chu mohamed vi- marrakech
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644706/
http://dx.doi.org/10.1093/ofid/ofab466.1596
work_keys_str_mv AT alaouizahidtalibi 1404tuberculosisandhivcoinfectionareviewof135casesexperienceoftheinfectiousdiseasesdepartmentchumohamedvimarrakech
AT raitebmohammed 1404tuberculosisandhivcoinfectionareviewof135casesexperienceoftheinfectiousdiseasesdepartmentchumohamedvimarrakech
AT ihbibanefatima 1404tuberculosisandhivcoinfectionareviewof135casesexperienceoftheinfectiousdiseasesdepartmentchumohamedvimarrakech
AT soraanabila 1404tuberculosisandhivcoinfectionareviewof135casesexperienceoftheinfectiousdiseasesdepartmentchumohamedvimarrakech
AT tassinoura 1404tuberculosisandhivcoinfectionareviewof135casesexperienceoftheinfectiousdiseasesdepartmentchumohamedvimarrakech